MedPath

Rivanex 10

Brand Name: Rivanex 10

Generic Name: Rivaroxaban

Active
Registration Number

DRP-15419

Dosage Form

Film-Coated Tablet

Issuance Date

August 1, 2024

Expiry Date

August 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg
PackagingAlu/PVC blister pack x 10's (Box of 30's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antithrombotic Agent (Direct Factor Xa Inhibitor)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RivaroxabanActive
Monograph: Rivaroxaban

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform